GlassScriptPhysician profile
Mason Mandy
NPI 1598924029
$1,824.01
in general payments reported to CMS, 2019-2025
10 companies · $71.42 in 2025
The $71.42 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $719 · 2020: $140 · 2021: $38.73 · 2022: $179 · 2023: $419 · 2024: $256 · 2025: $71.42.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $747.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $747.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $528.74 | 2019 | |
| Tactile Systems Technology INC | $438.08 | 2021-2024 | Flexitouch Plus, Entre Plus |
| Koya Medical, INC. | $239.98 | 2024 | Dayspring, Koya Medical |
| Boston Scientific Corporation | $225.53 | 2019-2020 | |
| Medtronic, INC. | $191.81 | 2022-2023 | Closurefast |
| Biocompatibles, INC. | $104.53 | 2019 | |
| Surgenex LLC | $29.69 | 2025 | Renograft, Surmatrix, Ardeograft |
| Allergan, INC. | $23.92 | 2021 | |
| Mimedx Group, INC. | $21.10 | 2025 | |
| Globus Medical, INC. | $20.63 | 2025 | Senza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mason Mandy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.